Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%

Stock Information for Surgalign Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Surgalign Holdings Inc.

Xtant Medical Announces the Launch of OsteoFactor Pro(TM)
Xtant Medical Reports First Quarter 2025 Financial Results
Xtant Medical to Issue First Quarter 2025 Financial Results on May 12, 2025
Xtant Medical Launches Trivium(TM) Advanced Bone Graft for Superior Performance
Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025
Xtant Medical Reports Third Quarter 2024 Financial Results
Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.